INS and type 2 diabetes mellitus: Previously, we have demonstrated that the skeletal muscle insulin resistance in obesity and type 2 diabetes associates with activation of the myocellular diacylglycerol (DAG)–novel protein kinase C (nPKC) isoform θ pathway, an inhibitory cascade of proximal insulin signalling [5, 6].